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Background: Recent study demonstrated that mast cells have various effects on the progression after acute myocardial infarction (MI). At acute 
phase, MI is involved with inflammation. This inflammation is regulated by neutrophil, monocyte, macrophage, and mast cell. We elucidated the 
effects of mast cell in a MI rat model.
Methods: To evaluate the effects of mast cell, we isolated the cell from rat peritoneal cavity and prepared mast cell granule (MCG) from purified 
mast cell by stimulation with compound 48/80. In vitro assay, we treated MCG to rat neonatal cardiomyocyte (rCMC) and exposed the cells into 
hypoxic condition (N2:95 %, CO2:5 %) and after 6 hours it returned to normoxic condition.
Results: In Propidium Iodide (PI) & Anexin assay, MCG treatment decreased death (necrosis and apoptosis) of rCMC. Survival cell ratio was 
86.3±3.5 % in normoxic condition, 65.2±3.2 % in hypoxic condition, and 73.3±7.1 % in hypoxic condition with MCG treatment. At the same cells with 
immunofluorescence staining, by FACS analysis and western blot analysis, hypoxic condition decreased troponin-I expression to 60 % level of normoxic 
condition. However, MCG treatment returned expression of troponin-I to the level of normoxic condition. And MCG treatment increased the expression of 
phosphorylation of Akt, ERK, and c-kit receptor. In vivo study, in a MI rat model, MCG injection into the infarct area improved left ventricular (LV) function 
and increased capillary density 3 times more than that of control rats (phosphate buffered saline injection) (p<0.05 in each).
Conclusions: The role of MCG on the regulation of angiogenesis and cell survival could result in improved LV function after MI.
